Page last updated: 2024-10-28

hydroxyurea and Pneumonia, Viral

hydroxyurea has been researched along with Pneumonia, Viral in 4 studies

Pneumonia, Viral: Inflammation of the lung parenchyma that is caused by a viral infection.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's4 (100.00)2.80

Authors

AuthorsStudies
DeBaun, MR1
Nickel, RS1
Margulies, S1
Frazer, B1
Luban, NLC1
Webb, J1
Novelli, EM1
Citron, F1
Perelli, L1
Deem, AK1
Genovese, G1
Viale, A1

Trials

1 trial available for hydroxyurea and Pneumonia, Viral

ArticleYear
Combination dose-escalated hydroxyurea and transfusion: an approach to conserve blood during the COVID-19 pandemic.
    Blood, 2020, 06-18, Volume: 135, Issue:25

    Topics: Adolescent; Adult; Anemia, Sickle Cell; Blood Donors; Blood Safety; Blood Transfusion; Chelation The

2020

Other Studies

3 other studies available for hydroxyurea and Pneumonia, Viral

ArticleYear
Initiating adjunct low-dose hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemic.
    Blood, 2020, 05-28, Volume: 135, Issue:22

    Topics: Anemia, Sickle Cell; Antisickling Agents; Blood Donors; Blood Safety; Blood Transfusion; Child; Chil

2020
COVID-19 and SCA: an old friend comes to the rescue.
    Blood, 2020, 05-28, Volume: 135, Issue:22

    Topics: Betacoronavirus; Child; Coronavirus Infections; COVID-19; Friends; Humans; Hydroxyurea; Pandemics; P

2020
Leukotrienes, a potential target for Covid-19.
    Prostaglandins, leukotrienes, and essential fatty acids, 2020, Volume: 161

    Topics: Acetates; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Betaco

2020